药物防治角膜移植术后免疫排斥的研究进展  

Effect of immunosuppressive agent on immunologic rejection after keratoplasty

作　　者：王旭[1] 刘伟[1] 吕国芳[1] 张华[1] 

机构地区：[1]山东省济南市第二人民医院眼科,250001

出　　处：《眼科新进展》2006年第4期309-312,共4页Recent Advances in Ophthalmology

摘　　要：应用药物治疗角膜移植术后免疫排斥,一直是眼科角膜病专业研究的重点内容之一。许多新型的免疫抑制剂得到了比较深入的研究,正在逐步应用到角膜移植术后免疫排斥的治疗中去。我们回顾了免疫抑制剂的发展和临床应用情况,分析了传统免疫抑制剂的作用效果和副作用,并介绍了目前一些新型免疫抑制剂的研究进展情况。For keratoplasty, it is very important to research effective drugs to reduce the immunologic rejection. Many new type immuno-suppressive agents have been studied recently. They were applicated to treat the postoperative immunologic rejection step by step. This paper reviews the progress of those classical immunosuppressive agents and the situation of clinical application and the effect and ill effect of those drugs and introduces the research progress of many new type immunosuppressive agents.

关 键 词：角膜移植 免疫排斥 免疫抑制剂 

分 类 号：R779.65[医药卫生—眼科]